Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Aminoglycoside antibiotic resistance through ribosomal RNA methylation. Edition No. 1

VDM Publishing House, Dec 2010, Pages: 164


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

In antibiotic producing bacteria two 16S rRNA methyltransferase families (MT) provide resistance against self-intoxication: Kam MT (m1A1408) and Kgm MT (m7G1405). Both these MT have their homologues in pathogenic bacteria, Arm and Pam MT families, respectively. These MT act at nucleotides in antibiotic binding site and methyl group addition sterically blocks antibiotic binding. Studies on Sgm from M. zionensis provided some initial insights on Kgm MT using sequence conservation and homology modelling. Recent structures showed that resistance MT, irrespective of their origin, have the same protein fold. However, corresponding protein sequences do not reflect conservation of the structure indicating that particular protein fold can be achieved with sequences sharing as little as 30% identity. In the same time conservation of the protein structure indicates that structural constraints are important for efficient target nucleotide selection on the 16S rRNA. Future key issue will be to determine the molecular mechanism of target site selection and whether specific features of recognition can be exploited to combat the rise of resistance to clinically useful aminoglycoside antibiotics.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds